Alcon Affiliate Receives FDA Approval Of Generic Anti-Infective Medication
10/19/2005 5:11:18 PM
The U.S. Food and Drug Administration today approved Falcon Pharmaceuticals, Ltd.'s (Falcon) generic Ofloxacin Ophthalmic Solution USP, 0.3%. Falcon is an affiliate of Alcon, Inc. (NYSE:ACL), the world's leading eye care company. Ofloxacin is therapeutically equivalent to Ocuflox(a) and is indicated for treating infections caused by susceptible strains of bacteria in both conjunctivitis and corneal ulcer conditions. The drug is available immediately, and comes in a Drop-tainer(b) dispenser in two sizes: 5mL and 10mL. At the time of manufacture, the product will have a 24-month shelf life.